Publications

Recent advances in CDC42 subfamily inhibition and therapeutic potential

 67
Recent advances in CDC42 subfamily inhibition and therapeutic potential

Tags:

Previous Article

Metabolic dysfunction from heat stress via skin-hypothalamus axis

Next Article

Inhibiting CDC42 subfamily to treat diseases

Related Posts

Tak1 licenses mitochondrial transfer from astrocytes to POMC neurons to maintain glucose and cholesterol homeostasis

Tak1 licenses mitochondrial transfer from astrocytes to...

 106

Multi-omic human pancreatic islet endoplasmic reticulum and cytokine stress response mapping provides type 2 diabetes genetic insights

Multi-omic human pancreatic islet endoplasmic reticulum...

 127

Catalytic neural stem cell exosomes for multi-stage targeting and synergistical therapy of retinal ischemia-reperfusion injury

Catalytic neural stem cell exosomes for multi-stage tar...

 107